OpenAlex
PricingAboutJobs
Log inGet started
Work

Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Mellitus

HTML

Year: 2008
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Journal of Clinical Pharmacology
DOI: 10.1177/0091270008323750
Authors: Prajakti A. Kothare, Helle Linnebjerg, Yoshitaka Isaka, Kazunori Uenaka, Ayuko Yamamura, Kwee Poo Yeo, Amparo de la Peña, Choo Hua Teng, Kenneth Mace, Mark Fineman, Hirofumi Shigeta, Yukikuni Sakata, Shin Irie
Institutions: Eli Lilly (United States), Eli Lilly (United Kingdom), Eli Lilly (Japan), National University of Singapore, SOUSEIKAI Global Clinical Research Center
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: exenatide, type 2 diabetes, pharmacokinetics, pharmacodynamics, tolerability, safety, postprandial blood glucose, dose-response relationship, Emax model, Japanese patients, GLP-1 receptor agonists
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2048929025
FWCI: 2.51
Cites: 43
Cited by: 64
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security